ANGIODYNAMICS INC·4

Jul 21, 8:21 PM ET

Nighan Warren JR 4

4 · ANGIODYNAMICS INC · Filed Jul 21, 2026

Research Summary

AI-generated summary of this filing

Updated

AngioDynamics (ANGO) SVP Nighan Warren Jr. Sells Shares

What Happened

  • Nighan Warren Jr., Senior Vice President, Quality and Regulatory at AngioDynamics (ANGO), disposed of a total of 3,777 shares in three transactions to satisfy tax-withholding obligations tied to vested restricted stock units (RSUs). The sales were: 2,153 shares @ $14.14 on 2026-07-16 ($30,443), 1,373 shares @ $13.51 on 2026-07-17 ($18,549), and 251 shares @ $13.71 on 2026-07-20 ($3,441). These were exempt dispositions for tax withholding (code F) and are routine sell-to-cover actions, not open-market investment decisions.

Key Details

  • Transaction dates and amounts:
    • 2026-07-16: 2,153 shares sold @ $14.14 = $30,443 (F1)
    • 2026-07-17: 1,373 shares sold @ $13.51 = $18,549 (F2)
    • 2026-07-20: 251 shares sold @ $13.71 = $3,441 (F3)
  • Total: 3,777 shares; total proceeds ≈ $52,433.
  • Footnotes: Each disposition was an exempt sale to satisfy tax withholding for RSU vesting from prior grants dated 7/16/2025 (F1), 7/17/2024 (F2), and 7/20/2022 (F3).
  • Transaction code: F — disposition to cover tax withholding on vested equity.
  • Shares owned after the transactions: not specified in the provided filing.
  • Timeliness: Filing date 2026-07-21. The 7/16 and 7/17 transactions appear to have been reported after the SEC’s typical two-business-day window (i.e., late); the 7/20 transaction was filed within one business day.

Context

  • These were sell-to-cover/tax-withholding transactions tied to RSU vesting, a common administrative action that does not necessarily reflect the insider’s view of the company’s prospects. For retail investors, purchases by insiders tend to be more informative than routine withholding sales.

Insider Transaction Report

Form 4
Period: 2026-07-16
Nighan Warren JR
SVP Quality and Regulatory
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-07-16$14.14/sh2,153$30,44367,750 total
  • Tax Payment

    Common Stock

    [F2]
    2026-07-17$13.51/sh1,373$18,54966,377 total
  • Tax Payment

    Common Stock

    [F3]
    2026-07-20$13.71/sh251$3,44166,126 total
Footnotes (3)
  • [F1]The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
  • [F2]The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
  • [F3]The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Signature
/s/ Lawrence T. Weiss, Attorney in Fact|2026-07-21

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4